デフォルト表紙
市場調査レポート
商品コード
1690007

アレルギー性鼻炎の市場規模、シェア、成長分析:タイプ別、治療別、投与経路別、剤形別、検査法別、流通チャネル別、地域別 - 産業予測 2025~2032年

Allergic Rhinitis Market Size, Share, and Growth Analysis, By Type (Seasonal, Perennial), By Treatment (Immunotherapy, Antihistamines), By Route of Administration, By Form, By Test, By Distribution Channel, By Region - Industry Forecast 2025-2032


出版日
発行
SkyQuest
ページ情報
英文 219 Pages
納期
3~5営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.91円
アレルギー性鼻炎の市場規模、シェア、成長分析:タイプ別、治療別、投与経路別、剤形別、検査法別、流通チャネル別、地域別 - 産業予測 2025~2032年
出版日: 2025年03月24日
発行: SkyQuest
ページ情報: 英文 219 Pages
納期: 3~5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

アレルギー性鼻炎市場規模は2023年に118億米ドルと評価され、2024年の122億4,000万米ドルから2032年には163億6,000万米ドルに成長し、予測期間(2025-2032年)のCAGRは3.7%で成長する見通しです。

アレルギー性鼻炎市場は、アレルギー疾患の有病率の上昇、環境条件の変化、治療オプションに対する意識の高まりによって推進されています。主な成長促進要因としては、革新的な治療薬の開発、主なヘルスケア支出の増加、より効果的な治療法の発見を目指した研究の進行などが挙げられます。しかし、市販薬の利用可能性などの課題が、処方薬の売上に影響を与えています。同市場は大手製薬企業によって支配されており、免疫療法ソリューションの進展に大きな力を注いでいます。治療方法の継続的な強化や個別化医療へのシフトといったポジティブな動向が、アレルギー性鼻炎の今後の展望を形成しています。全体として、この市場はアレルギー疾患への対応において大きな成長と革新の可能性を示しています。

目次

イントロダクション

  • 調査の目的
  • 調査範囲
  • 定義

調査手法

  • 情報調達
  • 二次と一次データの方法
  • 市場規模予測
  • 市場の前提条件と制限

エグゼクティブサマリー

  • 世界市場の見通し
  • 供給と需要の動向分析
  • セグメント別機会分析

市場力学と見通し

  • 市場概要
  • 市場規模
  • 市場力学
    • 促進要因と機会
    • 抑制要因と課題
  • ポーターの分析

主な市場の考察

  • 重要成功要因
  • 競合の程度
  • 主な投資機会
  • 市場エコシステム
  • 市場の魅力指数(2024年)
  • PESTEL分析
  • マクロ経済指標
  • バリューチェーン分析
  • 価格分析
  • 規制情勢
  • ケーススタディ
  • 技術の進歩

アレルギー性鼻炎市場規模:タイプ別& CAGR(2025-2032)

  • 市場概要
  • 季節性
  • 通年性
  • 職業性鼻炎

アレルギー性鼻炎市場規模:治療別& CAGR(2025-2032)

  • 市場概要
  • 免疫療法
  • 抗ヒスタミン薬
  • 充血除去薬
  • 脊椎固定術
  • コルチコステロイド
  • その他

アレルギー性鼻炎市場規模:投与経路別& CAGR(2025-2032)

  • 市場概要
  • 経口
  • 非経口
  • 鼻腔内

アレルギー性鼻炎市場規模:剤形別& CAGR(2025-2032)

  • 市場概要
  • 固体
  • 液体

アレルギー性鼻炎市場規模:検査法別& CAGR(2025-2032)

  • 市場概要
  • 皮膚テスト
  • IgE RAST検査
  • 完全血球計算

アレルギー性鼻炎市場規模:流通チャネル別& CAGR(2025-2032)

  • 市場概要
  • 病院薬局
  • 小売薬局
  • オンラインストア

アレルギー性鼻炎市場規模& CAGR(2025-2032)

  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • スペイン
    • フランス
    • 英国
    • イタリア
    • その他欧州地域
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカ
    • ブラジル
    • その他ラテンアメリカ地域
  • 中東・アフリカ
    • GCC諸国
    • 南アフリカ
    • その他中東・アフリカ

競合情報

  • 上位5社の比較
  • 主要企業の市場ポジショニング(2024年)
  • 主な市場企業が採用した戦略
  • 最近の市場動向
  • 企業の市場シェア分析(2024年)
  • 主要企業の企業プロファイル
    • 企業の詳細
    • 製品ポートフォリオ分析
    • 企業のセグメント別シェア分析
    • 収益の前年比比較(2022-2024)

主要企業プロファイル

  • ALK-Abello A/S(Denmark)
  • Chiesi Farmaceutici S.p.A.(Italy)
  • Sun Pharmaceutical Industries Limited(India)
  • Teva Active Pharmaceutical Ingredients(Israel)
  • GlaxoSmithKline plc(United Kingdom)
  • Merck & Co., Inc.(USA)
  • AstraZeneca plc(United Kingdom)
  • Novartis International AG(Switzerland)
  • Pfizer Inc.(USA)
  • Johnson & Johnson(USA)
  • Bayer AG(Germany)
  • Roche Holding AG(Switzerland)
  • AbbVie Inc.(USA)
  • Eli Lilly and Company(USA)
  • Boehringer Ingelheim GmbH(Germany)
  • Takeda Pharmaceutical Company Limited(Japan)
  • Mylan N.V.(USA)
  • Cipla Limited(India)
  • Dr. Reddy's Laboratories(India)

結論と提言

目次
Product Code: SQMIG35D2216

Allergic Rhinitis Market size was valued at USD 11.8 billion in 2023 and is poised to grow from USD 12.24 billion in 2024 to USD 16.36 billion by 2032, growing at a CAGR of 3.7% during the forecast period (2025-2032).

The allergic rhinitis market is being propelled by the rising prevalence of allergic disorders, shifting environmental conditions, and heightened awareness of treatment options. Key growth drivers include the development of innovative therapeutics, increasing healthcare expenditures, and ongoing research aimed at discovering more effective treatments. However, challenges such as the availability of over-the-counter medications are affecting prescription sales. The market is dominated by major pharmaceutical companies, with a significant focus on advancing immunotherapy solutions. Positive trends include continuous enhancements in treatment modalities and a shift towards personalized medicine, which are shaping the future of the allergic rhinitis landscape. Overall, the market exhibits considerable potential for growth and innovation in addressing allergic conditions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Allergic Rhinitis market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Allergic Rhinitis Market Segments Analysis

Global Allergic Rhinitis Market is segmented by Type, Treatment, Route of Administration, Form, Test, Distribution Channel and region. Based on Type, the market is segmented into Seasonal, Perennial and Occupational Rhinitis. Based on Treatment, the market is segmented into Immunotherapy, Antihistamines, Decongestants, Vertebral Fusion, Corticosteroids and Others. Based on Route of Administration, the market is segmented into Oral, Parenteral and Intranasal. Based on Form, the market is segmented into Solid and Liquid. Based on Test, the market is segmented into Skin Test, IgE RAST Test and Complete Blood Count. Based on Distribution Channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies and Online Stores. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Allergic Rhinitis Market

The global allergic rhinitis market is significantly propelled by the rising prevalence of the condition, influenced by environmental factors and lifestyle changes. This surge can be attributed to factors such as urbanization, heightened pollution levels, and increased exposure to allergens, all of which contribute to a higher demand for effective treatment solutions. As more individuals experience the discomfort associated with allergic rhinitis, the need for innovative therapies and management strategies is becoming increasingly critical, thereby driving growth within the market and prompting the development of new and enhanced treatments to address this widespread issue.

Restraints in the Allergic Rhinitis Market

A significant restraint in the allergic rhinitis market is the frequent underdiagnosis and undertreatment of the condition, primarily due to limited awareness and misunderstanding of symptoms among both patients and healthcare professionals. This issue is compounded by challenges related to access and affordability of medications, particularly in developing regions, which hinders effective management. Moreover, the complexities of regulatory frameworks and discrepancies in approval processes for allergy medications can impede market growth and the introduction of innovative treatment solutions. Addressing these barriers is essential for enhancing patient outcomes and advancing the overall market for allergic rhinitis.

Market Trends of the Allergic Rhinitis Market

The Allergic Rhinitis market is witnessing a significant shift towards precision medicine and personalized treatment approaches, reflecting an evolving understanding of individual patient profiles and allergen sensitivities. This trend emphasizes tailored interventions, allowing for more effective management of symptoms based on specific characteristics of each patient. Moreover, immunotherapy, particularly through sublingual and subcutaneous methods, is gaining traction as a long-term strategy for altering the disease's trajectory, rather than just managing symptoms. This evolution in treatment methodologies not only enhances patient outcomes but also fosters greater adherence to therapy, thereby driving market growth and innovation in the field of allergic rhinitis management.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Regulatory Landscape
  • Case Studies
  • Technological Advancement

Global Allergic Rhinitis Market Size by Type & CAGR (2025-2032)

  • Market Overview
  • Seasonal
  • Perennial
  • Occupational Rhinitis

Global Allergic Rhinitis Market Size by Treatment & CAGR (2025-2032)

  • Market Overview
  • Immunotherapy
  • Antihistamines
  • Decongestants
  • Vertebral Fusion
  • Corticosteroids
  • Others

Global Allergic Rhinitis Market Size by Route of Administration & CAGR (2025-2032)

  • Market Overview
  • Oral
  • Parenteral
  • Intranasal

Global Allergic Rhinitis Market Size by Form & CAGR (2025-2032)

  • Market Overview
  • Solid
  • Liquid

Global Allergic Rhinitis Market Size by Test & CAGR (2025-2032)

  • Market Overview
  • Skin Test
  • IgE RAST Test
  • Complete Blood Count

Global Allergic Rhinitis Market Size by Distribution Channel & CAGR (2025-2032)

  • Market Overview
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Stores

Global Allergic Rhinitis Market Size & CAGR (2025-2032)

  • North America (Type, Treatment, Route of Administration, Form, Test, Distribution Channel)
    • US
    • Canada
  • Europe (Type, Treatment, Route of Administration, Form, Test, Distribution Channel)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Type, Treatment, Route of Administration, Form, Test, Distribution Channel)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Type, Treatment, Route of Administration, Form, Test, Distribution Channel)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Type, Treatment, Route of Administration, Form, Test, Distribution Channel)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • ALK-Abello A/S (Denmark)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Chiesi Farmaceutici S.p.A. (Italy)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sun Pharmaceutical Industries Limited (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Teva Active Pharmaceutical Ingredients (Israel)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • GlaxoSmithKline plc (United Kingdom)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merck & Co., Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • AstraZeneca plc (United Kingdom)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Novartis International AG (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Pfizer Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Johnson & Johnson (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bayer AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Roche Holding AG (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • AbbVie Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Eli Lilly and Company (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Boehringer Ingelheim GmbH (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Takeda Pharmaceutical Company Limited (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Mylan N.V. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cipla Limited (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Dr. Reddy's Laboratories (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations